Other languages InspireMD, Inc.

Equities

NSPR

US45779A8466

Market Closed - Nasdaq Other stock markets 02:00:01 14/05/2024 am IST			5-day change	1st Jan Change
2.4 ^USD	+7.38%		+13.20%	-14.59%

06/03	Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024
06/03	Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
InspireMD Gets CE Mark Recertification From the European Union	01/02
InspireMD, Inc. Announces Appointment of Pete Ligotti as Executive Vice President and General Manager of North America	03/01
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions	27/11
InspireMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Inspiremd, Inc. Presents Positive 30-Day Follow-Up Results from the C-Guard®? U.S. Investigational Device Exemption Clinical Trial	01/11
InspireMD, Inc. Supports CMS? Final National Coverage Determination Expanding Coverage of Carotid Stenting to Include Both Asymptomatic and Standard Risk Patients	12/23/12
InspireMD, Inc. Announces Management Appointments	03/23/03
InspireMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/23/08
InspireMD, Inc. Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption Clinical Trial	26/23/26
Insider Buy: Inspiremd	17/23/17
Insider Buy: Inspiremd	17/23/17
Insider Buy: Inspiremd	17/23/17
Insider Buy: Inspiremd	17/23/17
InspireMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16
InspireMD to Raise Funds From Placement With Healthcare Investors; Shares Rise	16/23/16
InspireMD, Inc. Announces Successful First-In-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent Platform	01/23/01
InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30
InspireMD, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	30/23/30
InspireMD, Inc. Auditor Raises 'Going Concern' Doubt	30/23/30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages InspireMD, Inc.

Equities

NSPR

US45779A8466

Other languages

Filters